The parenteral segment held the highest market share in 2023 and is anticipated to retain this trend through 2032
5.2 Glucagon-like peptide-1 Glucagon-like peptide-1(GLP-1), a peptide hormone secreted by intestinal L-cells, has broad pharmacological potential for managing type 2 diabetes mellitus and metabolic syndrome-related disorders by binding to its receptor -GLP-1R
The same peptide in pre-mixed solution degrades to below acceptable potency in 28 to 56 days even under refrigeration (Buckley et al., Journal of Pharmaceutical Sciences , 2023)
Oversight is instead handled at the pharmacy and prescriber level under state and federal regulations
At Cymbiotika, we believe that understanding how your supplements interact is the first step toward a routine that actually works
Cui, X., Bray, S., Bryant, D